Search results for:
metoclopramide
metoclopramide
- Formulary Miscellaneous Program Formulary
- Restricted Metozolv ODT --> Restricted to patients that cannot take the tablet or solution and do not have an intravenous line.
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Reglan |
SOLUTION, INJECTABLE |
5 mg/mL |
|
|
|
|
| Gimoti |
SPRAY, NASAL |
15 mg |
|
|
|
|
| Reglan |
SYRUP, ORAL |
5 mg/5 mL |
|
|
|
|
| Metozolv ODT |
TABLET, DISINTEGRATING, ORAL |
5 mg |
|
|
|
|
| Reglan |
TABLET, ORAL |
5 mg, 10 mg |
|
|
|
|
Last updated: Aug. 14, 2026
Automatic renal adjustment per guidelines. CrCl less than 40 mL/min, use 50% of dose. Renal Adjustment Guidelines
METOZOLV was approved for restricted formulary use in patients that cannot take the tablet or solution and don't have an intravenous line.
GIMOTI (metoclopramide nasal spray): Non-Formulary. Inpatients should use their home supply if necessary.
Reviewed: December 2009 (METOZOLV), July 2026 (GIMOTI)
Metoclopramide (GIMOTI) Nasal Spray Spotlight.pdf